|
|
Volumn 39, Issue 4, 2011, Pages 920-923
|
|
The amyloid cascade hypothesis has misled the pharmaceutical industry
[No Author Info available]
|
|
Author keywords
Alzheimer's disease; Amyloid peptide (A ); Amyloid cascade hypothesis; Dementia; Pharmaceutical industry
|
|
Indexed keywords
AMYLOID;
AMYLOID BETA PROTEIN;
AMYLOID PRECURSOR PROTEIN;
APOLIPOPROTEIN E;
APOLIPOPROTEIN E4;
GLYCOGEN SYNTHASE KINASE 3;
HISTONE DEACETYLASE 3;
ALZHEIMER DISEASE;
AMYLOID PLAQUE;
AUTOPHAGY;
BRAIN NERVE CELL;
CONFERENCE PAPER;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG TARGETING;
EXPERIMENTAL MOUSE;
GLIOSIS;
HUMAN;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
NEUROPATHOLOGY;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
ANIMALS;
DEMENTIA;
DISEASE MODELS, ANIMAL;
DRUG INDUSTRY;
HUMANS;
PLAQUE, AMYLOID;
|
|
EID: 79960884523
PISSN: 03005127
EISSN: 14708752
Source Type: Journal
DOI: 10.1042/BST0390920 Document Type: Conference Paper |
|
Times cited : (15)
|
|
References (0)
|